Allucent
Marcus Delatte, PhD, has an extensive work experience history. Marcus started as a Postdoctoral Research Fellow at McLean Hospital/Harvard Medical School in 2004. In 2008, they transitioned to the Food and Drug Administration, where they served as a Senior Pharmacology/Toxicology Reviewer until 2019. From 2019 to 2021, they held roles at Parexel, first as a Principle Consultant and later as Vice President, Technical. Currently, they are the Vice President, Regulatory Strategy at Allucent.
Marcus Delatte, Ph.D. obtained a BA in Psychology from the University of New Orleans in 1999, and went on to earn a Ph.D. in Pharmacology from Louisiana State University Health Sciences Center in 2004.
This person is not in the org chart
This person is not in any offices
Allucent
Allucent offers consulting services. They provide paid search, shopping, performance, creative, consulting, and measurement services.